Xianping Lu
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Retinoids in leukemia and cellular processes
- Peroxisome Proliferator-Activated Receptors
- Epigenetics and DNA Methylation
Papers in
-
- Histone Deacetylase Inhibitors Research 12
- Protein Degradation and Inhibitors 8
- Peroxisome Proliferator-Activated Receptors 7
- Retinoids in leukemia and cellular processes 6
- Oncology 12
- Peptidase Inhibition and Analysis 6
- Co-authors
- Zhiqiang Ning (16 shared papers)Desi Pan (15 shared papers)Zhibin Li (6 shared papers)Haixiang Cao (5 shared papers)Mei Dong (3 shared papers)Magnus Pfahl (6 shared papers)Jing-Zhong Zhu (5 shared papers)Xinhao Wang (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)International Journal of Cancer (2 papers)PPAR Research (2 papers)Molecular and Cellular Biology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xianping Lu
42 papers receiving 1.7k citations
Xianping Lu's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 414
- Molecular Biology 1.1k
- Biochemistry 77
- Pathology and Forensic Medicine 205
- Hematology 91
Countries citing papers authored by Xianping Lu
This map shows the geographic impact of Xianping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianping Lu more than expected).
Fields of papers citing papers by Xianping Lu
This network shows the impact of papers produced by Xianping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianping Lu. The network helps show where Xianping Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianping Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 270 | |
| 2 | 2011 | 230 | |
| 3 | 2016 | 130 | |
| 4 | 2008 | 104 | |
| 5 | 2012 | 90 | |
| 6 | Advances in targeting histone deacetylase for treatment of solid tumors Hit paper breakdown → | 2024 | 79 |
| 7 | 1997 | 72 | |
| 8 | 2006 | 60 | |
| 9 | 1994 | 57 | |
| 10 | 2014 | 57 | |
| 11 | 2022 | 53 | |
| 12 | 2003 | 52 | |
| 13 | 2012 | 43 | |
| 14 | 2014 | 42 | |
| 15 | 2016 | 38 | |
| 16 | 2006 | 38 | |
| 17 | 1993 | 36 | |
| 18 | 2004 | 36 | |
| 19 | 1999 | 35 | |
| 20 | 2017 | 35 |
About Xianping Lu
Xianping Lu is a scholar working on Molecular Biology, Oncology, Physiology, Genetics and Cancer Research, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Retinoids in leukemia and cellular processes (6 papers), Peptidase Inhibition and Analysis (6 papers), Adipose Tissue and Metabolism (4 papers), Estrogen and related hormone effects (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Oncology (414 citations), Molecular Biology (1.1k citations), Biochemistry (77 citations), Pathology and Forensic Medicine (205 citations) and Hematology (91 citations). Xianping Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiqiang Ning, Desi Pan, Zhibin Li, Haixiang Cao, Mei Dong, Magnus Pfahl, Jing-Zhong Zhu, Xinhao Wang, Michael Newman and Xinhao Wang. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Bioorganic & Medicinal Chemistry Letters, International Journal of Cancer, PPAR Research and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.